Back to Search
MALCOLM MATTES, M.D.
M.D.
Radiation Oncology Physician
NPI: 1770889511IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
25MA10733800(NJ)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
UN OF CALIFORNIA, IRVINE, COLLEGE OF MEDICINE
Class of 2009
Research & Publications (20)
Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap.
PMID 19409040·Cancer Biother Radiopharm·2009
8-other
Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons.
PMID 18265976·Eur J Nucl Med Mol Imaging·2008
7-preclinical
The mechanism of killing of B-lymphoma cells by 111In-conjugated antibodies.
PMID 18464068·Int J Radiat Biol·2008
8-other
Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab).
PMID 18829494·Clin Cancer Res·2008
7-preclinical
CD74: a new candidate target for the immunotherapy of B-cell neoplasms.
PMID 17875789·Clin Cancer Res·2007
6-review
Apoptosis assays with lymphoma cell lines: problems and pitfalls.
PMID 17342089·Br J Cancer·2007
8-other
Adjusting to life after treatment: distress and quality of life following treatment for breast cancer.
PMID 18000503·Br J Cancer·2007
8-other
A divalent hapten-peptide induces apoptosis in human non hodgkin lymphoma cell lines targeted by anti-CD20xanti-hapten bispecific antibodies.
PMID 17875790·Clin Cancer Res·2007
8-other
Characterization of antibody-containing vesicles shed from B-lymphoma cell lines: exposure of annexin V binding sites.
PMID 17107914·Leuk Lymphoma·2006
8-other
Binding parameters of antibodies: pseudo-affinity and other misconceptions.
PMID 15627210·Cancer Immunol Immunother·2005
8-other
Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates.
PMID 15982582·Nucl Med Biol·2005
8-other
In vitro cytotoxicity of carcinoma cells with 111In-labeled antibodies to HER-2.
PMID 15956250·Mol Cancer Ther·2005
8-other
177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.
PMID 15820762·Nucl Med Biol·2005
7-preclinical
Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons.
PMID 15701868·Clin Cancer Res·2005
7-preclinical
Determination of antibody immunoreactive fraction.
PMID 15665614·Cancer Biother Radiopharm·2004
7-preclinical
Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments.
PMID 15452546·Br J Cancer·2004
8-other
In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting low-energy electrons.
PMID 15355929·Clin Cancer Res·2004
8-other
Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.
PMID 14695162·Clin Cancer Res·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 STADIUM DR
MORGANTOWN, WV 26506 - Phone
- (304) 598-4706
Quick Facts
- NPI
- 1770889511
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile